May 18, 2026

Incyte Corporation (INCY) Stock Analysis: Insight into Potential 13.84% Upside in the Biotech Sector

Incyte Corporation (NASDAQ: INCY) stands as a formidable player in the biotechnology sector, known for its innovative approaches to therapeutics targeting various severe health conditions. With a market capitalization of..

Agilent Technologies, Inc. (A) Stock Analysis: Unveiling a 43.86% Potential Upside in the Diagnostics & Research Sector

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is currently drawing attention from investors, thanks to its potential upside..

Haleon plc (HLN) Stock Analysis: What a 31% Potential Upside Means for Investors

Haleon plc (HLN), a prominent player in the Healthcare sector and the Drug Manufacturers – Specialty & Generic industry, presents a compelling case for investors looking for potential growth in..

Neurocrine Biosciences (NBIX) Stock Analysis: Strong Buy Ratings and 20% Upside Potential

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is making waves in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $15.93 billion, this San..

ResMed Inc. (RMD) Stock Analysis: Exploring a 34% Potential Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, has been at the forefront of providing innovative solutions for respiratory disorders. With a market capitalization of $29.28 billion,..

United Therapeutics Corporation (UTHR) Stock Analysis: Navigating a 16.71% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR), a significant player in the healthcare sector, specializes in addressing the unmet medical needs of patients with chronic and life-threatening diseases. With a market capitalization..

Universal Health Services, Inc. (UHS) Stock Analysis: A Strategic Look at 32.42% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands as a notable player in the healthcare sector, boasting a market capitalization of $10.21 billion. Specializing in medical care facilities, UHS operates through..

Hologic, Inc. (HOLX) Stock Analysis: Steady Growth with a Strong Focus on Women’s Health

Hologic, Inc. (NASDAQ: HOLX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market cap of $16.97 billion, the company..

STERIS plc (STE) Stock Analysis: Healthcare Giant with 21% Upside Potential

STERIS plc (NYSE: STE), a leader in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a projected upside of over 21%. With its extensive range..

Edwards Lifesciences Corporation (EW) Investor Outlook: Analyzing a 19.38% Potential Upside in the Healthcare Sector

Edwards Lifesciences Corporation (NYSE: EW), a leading entity in the healthcare sector specializing in medical devices, has recently garnered significant attention from investors. With a market capitalization of $46.86 billion,..

Natera, Inc. (NTRA) Investor Outlook: Exploring a 39.99% Upside with Strong Buy Ratings

Natera, Inc. (NASDAQ: NTRA) is making waves in the healthcare sector, standing out as a key player in the diagnostics and research industry. With a market capitalization of $26.69 billion,..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Growth Potential and Analyst Consensus Point to 35% Upside

IQVIA Holdings, Inc. (NYSE: IQV) represents a compelling opportunity within the diagnostics and research segment of the healthcare sector. With a market capitalization of $28.23 billion, the company stands as..

Ruffer challenges investors to rethink what safety means

Ruffer warns that investors may be mistaking familiar holdings for safe ones as market concentration, inflation and policy uncertainty reshape portfolio risk...

Insulet Corporation (PODD) Stock Analysis: A 69.62% Potential Upside Amidst Strong Revenue Growth

Insulet Corporation (NASDAQ: PODD), a significant player in the medical devices industry, has captured investor attention with its innovative insulin delivery systems. With a market capitalization of $10.21 billion, Insulet..

Centene Corporation (CNC) Stock Analysis: Navigating Investment Choices in a Challenging Market

Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, primarily focuses on providing managed care services to under-insured families and commercial organizations across the United States. With a..

Alcon Inc. (ALC) Investor Outlook: Unpacking the 38% Potential Upside

As Alcon Inc. (NYSE: ALC) continues to solidify its position in the healthcare sector, individual investors are taking note of the company’s potential for growth. With a market cap of..

Elevance Health, Inc. (ELV) Stock Analysis: Navigating a Stable Healthcare Giant with Strategic Growth Potential

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry, commands significant attention in the market with a robust market capitalization of $85.28 billion. Previously known as..

Danaher Corporation (DHR) Stock Analysis: Unlocking a 53% Potential Upside

Danaher Corporation (NYSE: DHR), a stalwart in the healthcare sector, primarily operating within the diagnostics and research industry, continues to capture investor attention with its robust business operations and significant..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a 66% Potential Upside Amid Robust Revenue Growth

Investors keen on the healthcare technology sector should turn their attention to Veeva Systems Inc. (NYSE: VEEV), a prominent player in the health information services industry. With a market capitalization..

CVS Health Corporation (CVS) Stock Analysis: A Stable Healthcare Giant with a 5.93% Potential Upside

CVS Health Corporation (NYSE: CVS) continues to be a formidable player in the healthcare sector, providing essential health solutions through its comprehensive array of services and products. With a market..

Search

Funds

May 18, 2026

Ruffer challenges investors to rethink what safety means

Ruffer warns that investors may be mistaking familiar holdings for safe ones as market concentration, inflation and policy uncertainty reshape portfolio risk...
Search

Funds

May 18, 2026

FTSE 100

Funds